Susan H. Eshleman

20.9k total citations
186 papers, 5.7k citations indexed

About

Susan H. Eshleman is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Susan H. Eshleman has authored 186 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Infectious Diseases, 159 papers in Virology and 47 papers in Epidemiology. Recurrent topics in Susan H. Eshleman's work include HIV/AIDS Research and Interventions (166 papers), HIV Research and Treatment (159 papers) and HIV/AIDS drug development and treatment (121 papers). Susan H. Eshleman is often cited by papers focused on HIV/AIDS Research and Interventions (166 papers), HIV Research and Treatment (159 papers) and HIV/AIDS drug development and treatment (121 papers). Susan H. Eshleman collaborates with scholars based in United States, South Africa and Uganda. Susan H. Eshleman's co-authors include J. Brooks Jackson, Philippa Musoke, Laura Guay, Francis Mmiro, Oliver Laeyendecker, Lynne Mofenson, Anthony Mwatha, Deborah Donnell, Shawn Cunningham and Mary Glenn Fowler and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Nature Methods.

In The Last Decade

Susan H. Eshleman

182 papers receiving 5.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan H. Eshleman United States 41 4.7k 3.5k 1.5k 738 440 186 5.7k
Tobias F. Rinke de Wit Netherlands 41 3.9k 0.8× 3.1k 0.9× 1.3k 0.9× 644 0.9× 316 0.7× 169 5.7k
Ibou Thior United States 30 2.7k 0.6× 2.2k 0.6× 1.2k 0.8× 547 0.7× 362 0.8× 73 3.9k
James F. Rooney United States 40 3.9k 0.8× 2.5k 0.7× 2.5k 1.6× 514 0.7× 833 1.9× 114 5.9k
Mauro Schechter Brazil 28 3.4k 0.7× 1.6k 0.5× 1.7k 1.1× 508 0.7× 538 1.2× 62 3.9k
Laura Guay United States 31 4.0k 0.9× 2.6k 0.7× 1.2k 0.8× 990 1.3× 607 1.4× 106 4.6k
Peter Mugyenyi Uganda 39 4.1k 0.9× 2.2k 0.6× 1.9k 1.2× 676 0.9× 490 1.1× 139 5.3k
Richard Marlink United States 37 4.2k 0.9× 3.6k 1.0× 1.7k 1.1× 565 0.8× 732 1.7× 128 6.0k
Mauro Schechter Brazil 34 4.6k 1.0× 3.3k 0.9× 1.6k 1.0× 322 0.4× 1.3k 3.0× 71 5.6k
Francis Mmiro United States 28 3.4k 0.7× 2.3k 0.6× 1.3k 0.8× 844 1.1× 520 1.2× 67 4.4k
Fujie Zhang China 30 3.1k 0.6× 1.4k 0.4× 1.4k 0.9× 289 0.4× 491 1.1× 179 4.1k

Countries citing papers authored by Susan H. Eshleman

Since Specialization
Citations

This map shows the geographic impact of Susan H. Eshleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan H. Eshleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan H. Eshleman more than expected).

Fields of papers citing papers by Susan H. Eshleman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan H. Eshleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan H. Eshleman. The network helps show where Susan H. Eshleman may publish in the future.

Co-authorship network of co-authors of Susan H. Eshleman

This figure shows the co-authorship network connecting the top 25 collaborators of Susan H. Eshleman. A scholar is included among the top collaborators of Susan H. Eshleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan H. Eshleman. Susan H. Eshleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Sue, Gordon Chau, Leslie Cottle, et al.. (2020). Brief Report: Hormonal Contraception Use and Cabotegravir Pharmacokinetics in HIV-Uninfected Women Enrolled in HPTN 077. JAIDS Journal of Acquired Immune Deficiency Syndromes. 85(1). 93–97. 11 indexed citations
2.
Köbe, Julia, Octavious Talbot, I‐Ming Chen, et al.. (2019). Short Communication: Viral Genetic Linkage Analysis Among Black Men Who Have Sex With Men (HIV Prevention Trials Network 061). AIDS Research and Human Retroviruses. 35(5). 434–436.
3.
Laeyendecker, Oliver, Jacob Konikoff, Douglas E. Morrison, et al.. (2018). Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection. Journal of the International AIDS Society. 21(2). 21 indexed citations
4.
Konikoff, Jacob, Allison Kirkpatrick, Charles Morrison, et al.. (2017). Short Communication: Comparison of Maxim and Sedia Limiting Antigen Assay Performance for Measuring HIV Incidence. AIDS Research and Human Retroviruses. 33(6). 555–557. 7 indexed citations
5.
Kirkpatrick, Allison, Eshan U. Patel, Connie Celum, et al.. (2016). Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations. AIDS Research and Human Retroviruses. 32(8). 756–762. 6 indexed citations
6.
Morrison, Charles, Pai‐Lien Chen, Eric J. Arts, et al.. (2014). Comparison of Antibody Responses to HIV Infection in Ugandan Women Infected with HIV Subtypes A and D. AIDS Research and Human Retroviruses. 31(4). 421–427. 13 indexed citations
7.
Marzinke, Mark A., William Clarke, Lei Wang, et al.. (2013). Nondisclosure of HIV Status in a Clinical Trial Setting: Antiretroviral Drug Screening Can Help Distinguish Between Newly Diagnosed and Previously Diagnosed HIV Infection. Clinical Infectious Diseases. 58(1). 117–120. 45 indexed citations
8.
Mullis, Caroline E., Supriya Munshaw, M. Kate Grabowski, et al.. (2013). Differential Specificity of HIV Incidence Assays in HIV Subtypes A and D-Infected Individuals from Rakai, Uganda. AIDS Research and Human Retroviruses. 29(8). 1146–1150. 13 indexed citations
9.
Serwadda, David, Fred Nalugoda, Godfrey Kigozi, et al.. (2013). Impact of HIV Subtype on Performance of the Limiting Antigen-Avidity Enzyme Immunoassay, the Bio-Rad Avidity Assay, and the BED Capture Immunoassay in Rakai, Uganda. AIDS Research and Human Retroviruses. 30(4). 339–344. 32 indexed citations
10.
Redd, Andrew D., Oliver Laeyendecker, Xiangrong Kong, et al.. (2011). Efficiency of CCR5 Coreceptor Utilization by the HIV Quasispecies Increases over Time, But Is Not Associated with Disease Progression. AIDS Research and Human Retroviruses. 28(3). 289–294. 6 indexed citations
11.
Gupta, Amita, Girish N. Nadkarni, Devidas N. Chaturbhuj, et al.. (2010). One-, Two-, and Three-Class Resistance among HIV-Infected Patients on Antiretroviral Therapy in Private Care Clinics: Mumbai, India. AIDS Research and Human Retroviruses. 26(1). 25–31. 19 indexed citations
12.
Ray, Stuart C., Lei Wang, Deborah Donnell, et al.. (2010). Analysis of HIV Diversity Using a High-Resolution Melting Assay. AIDS Research and Human Retroviruses. 26(8). 913–918. 27 indexed citations
13.
Church, Jessica D., James R. Eshleman, Mary Glenn Fowler, et al.. (2008). Analysis of Nevirapine Resistance Mutations in Cloned HIV Type 1 Variants from HIV-Infected Ugandan Infants Using a Single-Step Amplification-Sequencing Method (AmpliSeq). AIDS Research and Human Retroviruses. 24(9). 1209–1213. 3 indexed citations
14.
Eshleman, Susan H., Sarah E. Hudelson, R. Douglas Bruce, et al.. (2007). Analysis of HIV Type 1 gp41 Sequences in Diverse HIV Type 1 Strains. AIDS Research and Human Retroviruses. 23(12). 1593–1598. 8 indexed citations
15.
Church, Jessica D., Sarah E. Hudelson, Laura Guay, et al.. (2007). Short Communication: HIV Type 1 Variants with Nevirapine Resistance Mutations Are Rarely Detected in Antiretroviral Drug-Naive African Women with Subtypes A, C, and D. AIDS Research and Human Retroviruses. 23(6). 764–768. 14 indexed citations
16.
Eshleman, Susan H., Dana Jones, Ellen E. Paxinos, et al.. (2006). Phenotypic Drug Resistance Patterns in Subtype A HIV-1 Clones with Nonnucleoside Reverse Transcriptase Resistance Mutations. AIDS Research and Human Retroviruses. 22(3). 289–293. 21 indexed citations
17.
Eshleman, Susan H., Sarah E. Hudelson, Amita Gupta, et al.. (2005). Limited Evolution in the HIV Type 1 pol Region among Acute Seroconverters in Pune, India. AIDS Research and Human Retroviruses. 21(1). 93–97. 16 indexed citations
18.
Jones, Dana, Neil Parkin, Sarah E. Hudelson, et al.. (2005). Genetic Linkage of Nevirapine Resistance Mutations in HIV Type 1 Seven Days after Single-Dose Nevirapine. AIDS Research and Human Retroviruses. 21(4). 319–324. 4 indexed citations
19.
Eshleman, Susan H., Laura Guay, Anthony Mwatha, et al.. (2004). Comparison of Nevirapine (NVP) Resistance in Ugandan Women 7 Days vs. 6–8 Weeks after Single-Dose NVP Prophylaxis: HIVNET 012. AIDS Research and Human Retroviruses. 20(6). 595–599. 56 indexed citations
20.
Krogstad, Paul, Susan H. Eshleman, Yongzhi Geng, et al.. (2002). Mother-to-Child Transmission in the United States of Subtypes D and A/G Human Immunodeficiency Virus Type 1. AIDS Research and Human Retroviruses. 18(6). 413–417. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026